10,000 results · 19ms · Sources: EU EUDAMED, US FDA

C-PEPTIDE

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

C-PEPTIDE

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

C-PEPTIDE

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

C-PEPTIDE

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CARCINOEMBRYONIC ANTIGEN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CARCINOEMBRYONIC ANTIGEN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CARCINOEMBRYONIC ANTIGEN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CARCINOEMBRYONIC ANTIGEN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CARCINOEMBRYONIC ANTIGEN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CARCINOEMBRYONIC ANTIGEN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 15-3

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 15-3

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 15-3

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 15-3

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 15-3

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 15-3

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 72-4

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 72-4

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 72-4

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 72-4

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market